乙二胺四乙酸四钠, GR,99.9%,Tetrasodium Ethylenediaminetetraacetate Dihydrate

产品编号:西域试剂-WR380035| CAS NO:64-02-8| MDL NO:MFCD00150026| 分子式:C10H12N2Na4O8| 分子量:380.17

乙二胺四乙酸(EDTA)四钠是一种金属螯合剂(与包括钙在内的金属二价和三价阳离子结合),具有抗凝血和抗高钙血症的活性。乙二胺四乙酸四钠减少了金属离子催化的对蛋白质的氧化损伤,并允许在蛋白质纯化过程中维持还原环境。乙二胺四乙酸四钠也可以减少二硫键的形成。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
西域试剂-WR380035
68.00 杭州 北京(现货)
西域试剂-WR380035
166.00 杭州 北京(现货)
西域试剂-WR380035
478.00 杭州 北京(现货)
西域试剂-WR380035
1638.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

英文名称Tetrasodium Ethylenediaminetetraacetate Dihydrate
CAS编号64-02-8
产品描述乙二胺四乙酸(EDTA)四钠是一种金属螯合剂(与包括钙在内的金属二价和三价阳离子结合),具有抗凝血和抗高钙血症的活性。乙二胺四乙酸四钠减少了金属离子催化的对蛋白质的氧化损伤,并允许在蛋白质纯化过程中维持还原环境。乙二胺四乙酸四钠也可以减少二硫键的形成。
产品熔点>300 °C(lit.)
产品沸点614.2ºC at 760 mmHg
产品密度6.9 g/cm3
产品闪点325.2ºC
精确质量380.018433
PSA167.00000
外观性状白色奶油色粉末
溶解性H2O: 0.1 g/mL, clear, colorless
稳定性Stable. Incompatible with strong oxidizing agents.
储存条件

本品应密封于阴凉干燥处避光保存。

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


危害码 (欧洲) Xi:Irritant;
风险声明 (欧洲) R36/38
安全声明 (欧洲) S26-S36/37-S37/39
WGK德国 2
RTECS号 AH5075000
海关编码 2922499990

Section 1: Product Identification
Chemical Name:Ethylenediaminetetraacetic acid, tetrasodium salt tetrahydrate, 99+%
CAS Registry Number:64-02-8
Formula:(NaOOCH2)2NCH2CH2N(CH2COONa)2.4H2O
EINECS Number:200-573-9
Chemical Family:organic amine
Synonym:N,N'-Ethylenediaminediacetic acid tetrasodium salt, Tetrasodium EDTA

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound64-02-8100%no datano data

Section 3: Hazards Identification
Emergency Overview:Irritating to eyes, skin, and respiratory tract.
Primary Routes of Exposure:Eyes, Inhalation of dust.
Eye Contact:Irritating to eyes. May cause redness and pain.
Skin Contact:Mildly irritating to skin. May cause itching and redness.
Inhalation:Dust may be irritating to the nose, mucous membranes and respiratory tract.
Ingestion:No specific information is available on the physiological effects of ingestion.
Acute Health Affects:Irritating to skin, eyes and respiratory tract.
Chronic Health Affects:No information available on long-term chronic effects.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:no data
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:dry chemical, carbon dioxide, water fog, or foam.
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic organic fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Small spills can be mixed with vermiculite, sodium carbonate or other suitable non combustible adsorbent and
Spill and Leak Procedures:
swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a tightly sealed container. Keep away from heat and direct sunlight.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear appropriate chemical resistant gloves and clothing.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:white xtl.
Molecular Weight:380.18 (452.23)
Melting Point:no data
Boiling Point:no data
Vapor Pressure:not applicable
Specific Gravity:no data
Odor:none
Solubility in Water:soluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:oxidizing agents
Decomposition Products:carbon monoxide, carbon dioxide, organic fumes, sodium oxide, sodium hydroxide and nitrogen oxides.

SECTION 11: Toxicological Information
Administration onto the skin (rabbit); Standard Draize test: 500 mg/24H. Administration into the eye (rabbit);
RTECS Data:Standard Draize test: 1900 ug. Administration into the eye (rabbit); Standard Draize test: 100 mg/24H.
Intraperitoneal (mouse); LD50: 330 mg/kg.
Carcinogenic Effects:no data
Mutagenic Effects:no data
Tetratogenic Effects:no data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Listed in the TSCA inventory.
SARA (Title 313):Title compound not listed.
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

~%

64-02-8结构式

64-02-8

文献:Moran, Edmund J.; Fournier, Eric Patent: US2004/6102 A1, 2004 ; US 20040006102 A1

~%

64-02-8结构式

64-02-8

文献:Esteban, M. F. Gargallo; Serrano, Vilaplana R.; Vilchez, F. Gonzalez Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy, 1987 , vol. 43, # 8 p. 1039 - 1044

~%

64-02-8结构式

64-02-8

文献:DOW GLOBAL TECHNOLOGIES LLC.; MOORE, J. W., Jr.; BOOTH, Steven, T.; LEENHOUTS, Ray, O. Patent: WO2011/146582 A2, 2011 ; Location in patent: Page/Page column 10-11 ;

服务热线

13911702513
18601927057

微信客服